Analyst Expect Big Moves From Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 390.76M common shares owned by the public and among those 323.81M shares have been available to trade. The company’s stock has a 5-day price change of 2.08% and 5.04% over the past three months. RXRX shares are trading 1.78% year to date (YTD), with the 12-month market performance down to -30.43% lower. […]
Recursion Pharmaceuticals Inc (RXRX) Volatility Spurs A Quest For Clarity
Currently, there are 390.76M common shares owned by the public and among those 323.50M shares have been available to trade. The company’s stock has a 5-day price change of -4.58% and 11.87% over the past three months. RXRX shares are trading 1.78% year to date (YTD), with the 12-month market performance down to -48.66% lower. […]
Why Should You Put Recursion Pharmaceuticals Inc (NASDAQ: RXRX) On Your Portfolio?
Currently, there are 390.76M common shares owned by the public and among those 323.51M shares have been available to trade. The company’s stock has a 5-day price change of 1.83% and 28.71% over the past three months. RXRX shares are trading 15.38% year to date (YTD), with the 12-month market performance down to -19.50% lower. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): The Best-Of-Breed For Investing?
Currently, there are 390.76M common shares owned by the public and among those 323.51M shares have been available to trade. The company’s stock has a 5-day price change of 21.35% and 5.87% over the past three months. RXRX shares are trading -25.05% year to date (YTD), with the 12-month market performance down to -30.93% lower. […]
Handle With Care: Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 390.76M common shares owned by the public and among those 323.88M shares have been available to trade. The company’s stock has a 5-day price change of -6.05% and 2.19% over the past three months. RXRX shares are trading -29.11% year to date (YTD), with the 12-month market performance down to -28.96% lower. […]
Value Hunters: Look To Recursion Pharmaceuticals Inc (RXRX)
Currently, there are 388.78M common shares owned by the public and among those 322.67M shares have been available to trade. The company’s stock has a 5-day price change of -10.04% and 10.06% over the past three months. RXRX shares are trading -24.54% year to date (YTD), with the 12-month market performance down to -21.93% lower. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Hogging The Spotlight Today
Currently, there are 388.78M common shares owned by the public and among those 302.39M shares have been available to trade. The company’s stock has a 5-day price change of 13.30% and 30.88% over the past three months. RXRX shares are trading -18.76% year to date (YTD), with the 12-month market performance up to 7.95% higher. […]
Recursion Pharmaceuticals Inc (RXRX) Testing Investors’ Patience Right Now
Currently, there are 183.21M common shares owned by the public and among those 146.52M shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 56 of these insider trades were purchases, […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) – Suitable For Long Term Buy?
Currently, there are 183.21M common shares owned by the public and among those 151.91M shares have been available to trade. Insiders at the company have transacted a total of 143 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 61 of these insider trades were purchases, […]
Now Is A Suitable Moment For A Long-Term Purchase Of Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 183.21M common shares owned by the public and among those 151.89M shares have been available to trade. Insiders at the company have transacted a total of 153 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 65 of these insider trades were purchases, […]
